SRBAL System

About Ponte Biosciences

Ponte Biosciences is an early-stage biotech company developing a novel bioartificial liver system for acute liver failure, a condition with high mortality and limited treatment options. Its foundational technology, the SRBAL System, originated from the Mayo Clinic and is designed to support patients in intensive care. The company's mission extends beyond the device itself to solving the broader supply constraint of functional human hepatocytes, which could enable applications in cell therapy, gene therapy, and toxicology research. As a preclinical, private company, Ponte is positioned at the intersection of tissue engineering and critical care medicine.

Therapeutic Areas